0001437749-22-027949.txt : 20221123
0001437749-22-027949.hdr.sgml : 20221123
20221123083028
ACCESSION NUMBER: 0001437749-22-027949
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221121
FILED AS OF DATE: 20221123
DATE AS OF CHANGE: 20221123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLEMP WALTER V
CENTRAL INDEX KEY: 0000938419
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37758
FILM NUMBER: 221412368
MAIL ADDRESS:
STREET 1: 1415 WEST LOOP NORTH
CITY: HOUSTON
STATE: TX
ZIP: 77055
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moleculin Biotech, Inc.
CENTRAL INDEX KEY: 0001659617
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474671999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5300 MEMORIAL DRIVE
STREET 2: SUITE 950
CITY: HOUSTON
STATE: TX
ZIP: 77007
BUSINESS PHONE: 713-300-5160
MAIL ADDRESS:
STREET 1: 5300 MEMORIAL DRIVE
STREET 2: SUITE 950
CITY: HOUSTON
STATE: TX
ZIP: 77007
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-11-21
0001659617
Moleculin Biotech, Inc.
MBRX
0000938419
KLEMP WALTER V
C/O MOLECULIN BIOTECH, INC.
5300 MEMORIAL DR., SUITE 950
HOUSTON
TX
77007
1
1
CEO and President
Common Stock
2022-11-21
4
P
0
22500
1.1496
A
364890
D
This transaction was executed in multiple trades at prices ranging from $1.12 to $1.17. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Jonathan P. Foster by Power of Attorney
2022-11-23